Among 42 2- to 17-year-olds with juvenile idiopathic arthritis who were aggressively treated with weekly injections of methotrexate and etanercept, plus prednisolone, 30 reported being symptom-free at least once during their six-week treatment, a study showed. Symptoms in the aggressive treatment group also disappeared more quickly than in the group treated with methotrexate and placebos. The study, presented at the annual meeting of the American College of Rheumatology, "reinforces the importance of treating [juvenile idiopathic arthritis] early and aggressively in order to achieve and sustain clinical inactive disease," study author Carol Wallace said.

Full Story:

Related Summaries